Valentine, WJ: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

PDB8 CLINICAL BENEFITS OF PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) AND EZETIMIBE IN STATIN-TREATED TYPE-2 DIABETES PATIENTS FAILING TO REACH TARGET CHOLESTEROL LEVELS

D Liens, S Roze, WJ Valentine, ME Minshall, AJ Palmer, C Renaudin

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

2

Systematic Literature Review of Health State Utilities for Adults With Type 1 Diabetes

Smith-Palmer, J, Boye, KS, Bae, J, Norrbacka, K, Hunt, B, Valentine, WJ

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 49 KB

english, 2015

3

Evaluating the Long-Term Impact of Improving Care for Patients with Type 2 Diabetes in China

Wang, LM, Ye, Q, Kjerkegaard Nielsen, O, Gadegaard, A, Valentine, WJ, Hunt, B, Wang, LH

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 59 KB

english, 2017

4

Cost-consequence analysis in a French setting of screening and optimal treatment of nephropathy in hypertensive patients with type 2 diabetes

AJ Palmer, R Chen, WJ Valentine, S Roze, B Bregman, N Mehin, S Gabriel

Journal:

Diabetes & Metabolism

Year:

2006

File:

PDF, 122 KB

2006

5

PCV69 COST-EFFECTIVENESS OF ADD-ON THERAPY WITH PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) IN STATIN-TREATED PATIENTS WITH DYSLIPIDEMIA AND PERSISTENTLY LOW HDL-C IN THE UK AND GERMANY

S Roze, WJ Valentine, ME Minshall, AJ Palmer, D Liens, C Renaudin

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

6

PCV68 COST-EFFECTIVENESS OF RAISING HDL-CWITH PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) IN STATIN-TREATED PATIENTS WITH PERSISTENT DYSLIPIDEMIA IN AUSTRIAN, SWEDISH AND NORWEGIAN SETTINGS

S Roze, WJ Valentine, AJ Palmer, ME Minshall, D Liens, C Renaudin

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 63 KB

english, 2005

7

PDB20 BIPHASIC INSULIN ASPART 30 VERSUS ORAL HYPOGLYCEMIC AGENTS IN THE TREATMENT OF TYPE-2 DIABETES: LONG-TERM PROJECTION OF CLINICAL AND COST OUTCOMES IN SWEDEN

AJ Palmer, M Lammert, WJ Valentine, JA Ray, AS Brandt, S Roze

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 65 KB

english, 2005

8

PDB19 ECONOMIC EVALUATION OF SWITCHING TYPE-1 DIABETES PATIENTS FROM LONG-ACTING INSULIN GLARGINE INA BASAL/BOLUS REGIMEN TO LONG-ACTING INSULIN DETEMIR IN AN AUSTRIAN SETTING

AJ Palmer, KU Wittrup-Jensen, JB Hansen, S Roze, WJ Valentine

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 65 KB

english, 2005

9

PDB21 COST-EFFECTIVENESS ANALYSIS OF BASAL/BOLUS THERAPY IN TYPE-1 DIABETES USING INSULIN DETEMIR + INSULIN ASPART OR HUMAN SOLUBLE INSULIN-BASED BASAL/BOLUS REGIMENS IN GERMANY

WJ Valentine, KU Wittrup-Jensen, AJ Palmer, S Roze

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 83 KB

english, 2005

10

PDB27 COST-EFFECTIVENESS OFACARBOSE IN ADDITION TO EXISTING TREATMENTS IN TYPE-2 DIABETES IN GERMANY

S Roze, WJ Valentine, T Evers, AJ Palmer

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 64 KB

english, 2005

11

PDB28 COST-EFFECTIVENESS ANALYSES OF BASAL-BOLUS THERAPY OF TYPE-1 DIABETES USING INSULIN DETEMIR + HUMAN SOLUBLE INSULIN VERSUS NEUTRAL PROTAMINE HAGEDORM + HUMAN SOLUBLE INSULIN REGIMENS IN GERMANY

WJ Valentine, AJ Palmer, KU Wittrup-Jensen, S Roze

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 64 KB

english, 2005

12

PDB33 COST-CONSEQUENCE ANALYSIS OF SCREENING AND OPTIMIZED TREATMENT OF NEPHROPATHY IN HYPERTENSIVE PATIENTS WITH TYPE-2 DIABETES INA FRENCH SETTING

AJ Palmer, WJ Valentine, S Roze, R Chen, S Gabriel, B Bregman, N Mehin, HH Parving

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 63 KB

english, 2005

13

PDB39 EVALUATION OF THE COST-UTILITY OF INSULIN DETEMIR COMPARED TO INSULIN GLARGINE, BOTH IN COMBINATION WITH INSULIN ASPART INTYPE-I DIABETES IN GERMANY AND AUSTRIA

S Roze, KU Wittrup-Jensen, WJ Valentine, AJ Palmer

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 81 KB

english, 2005

14

PDB52 TYPE-2 DIABETES MODELS THAT DO NOT ACCOUNT FOR MICROVASCULAR DISEASE SCREENING RATESAND IMPORTANT CONCOMITANT MEDICATION USE MAY LEAD TO SUBSTANTIAL MISREPRESENTATION OF THE COST-EFFECTIVENESS OF NEW MEDICATIONS

AJ Palmer, WJ Valentine, ME Minshall, S Roze

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 59 KB

english, 2005

15

PDB40 COST-UTILITY ANALYSIS IN A USA SETTING OF SCREENING AND OPTIMIZED TREATMENT OF NEPHROPATHY IN HYPERTENSIVE PATIENTS WITH TYPE-2 DIABETES

AJ Palmer, R Chen, WJ Valentine, S Roze, S Gabriel, N Mehin, B Bregman, R Rodby

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 63 KB

english, 2005

16

PDB24 ASSESSMENT OF THE LONG-TERM COST-EFFECTIVENESS OF INSULIN ASPART + METFORMIN VERSUS HUMAN INSULIN + METFORMIN REGIMENS IN TYPE-2 DIABETES IN GERMANY BASED ON THE CLINICAL FINDINGS OF THE PHAZIT STUDY

S Roze, KU Wittrup-Jensen, C Haüser, WJ Valentine, AJ Palmer

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 83 KB

english, 2005

17

PDB23 ECONOMIC EVALUATION OF DETEMIR-BASED BASAL/BOLUS THERAPY VERSUS NPH-BASED BASAL/BOLUS THERAPY FOR TYPE-1 DIABETES IN GERMANY

AJ Palmer, WJ Valentine, KU Wittrup-Jensen, S Roze

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 64 KB

english, 2005

18

PDB9 PROJECTED IMPACT ON CORONARY HEART DISEASE AT 5, 10 AND 35 YEARS OF ADDING PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) TO STATIN TREATMENT IN PATIENTS WITH TYPE-2 DIABETES

C Renaudin, S Roze, AJ Palmer, WJ Valentine, ME Minshall, D Liens

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 60 KB

english, 2005

19

PDB25 FIXED COMBINATION METFORMIN PLUS GLIBENCLAMIDE (GLUCOVANCE®) IS COST AND LIFE SAVING COMPARED TO METFORMIN PLUS ROSIGLITAZONE IN TYPE-2 DIABETES PATIENTS IN FRANCE

N Cugnardey, S Roze, AJ Palmer, ME Minshall, WJ Valentine, C Renaudin

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 65 KB

english, 2005

20

PDB18 COST-EFFECTIVENESS OF ADD-ON PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) THERAPY IN DIABETIC VERSUS NON-DIABETIC PATIENTS WITH DYSLIPIDEMIA: A UK PERSPECTIVE

B Paschen, S Roze, AJ Palmer, WJ Valentine, D Liens, C Renaudin

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

21

PDB56 AN ASSESSMENT OF THE LONG-TERM OUTCOME FOR LIRAGLUTIDE+METFORMIN VERSUS METFORMIN AND VERSUS METFORMIN+GLIMEPIRIDE INTYPE-2 PATIENTS WITH INADE-QUATE GLYCAEMIC CONTROL

M Hammer, WJ Valentine, KU Wittrup-Jensen, AJ Palmer

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 65 KB

english, 2005

22

PDB17 ECONOMIC ASSESSMENT OF ADD-ON THERAPY WITH PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) IN STATIN-TREATED PATIENTS WITH DYSLIPIDEMIA AND TYPE-2 DIABETES IN GERMANY AND SWEDEN

W Berger, S Roze, AJ Palmer, WJ Valentine, D Liens, C Renaudin

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 63 KB

english, 2005

23

PDB45 CANADIAN COST UTILITY ANALYSIS COMPARING EXENATIDE VERSUS INSULIN GLARGINE IN PATIENTS WITH TYPE TWO DIABETES

D Coyle, K Coyle, WJ Valentine, JB Lee, R Kisswani, KS Boye

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 65 KB

english, 2008

24

PDB24 LONG-TERM CLINICAL AND COST OUTCOMES OF TREATMENT WITH INSULIN DETEMIR PLUS INSULIN ASPART IN TYPE I DIABETES PATIENTS IN THE CZECH SETTING; DATA FROM THE PREDICTIVE STUDY

JP Clegg, WJ Valentine, K Rychna, M Honka, T Dolezal

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 70 KB

english, 2008

25

PDB39 EFFECT OF VARYING MODELLING ASSUMPTIONS ON THE COSTEFFECTIVENESS OF LIRAGLUTIDE 1.2 MG (AS A COMPONENT OF DUAL THERAPY) IN TYPE 2 DIABETES

WJ Valentine, BD Chubb, IC Smith

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 98 KB

english, 2010

26

PCV51 IRBESARTAN IS COST-SAVING COMPARED TO AMLODIPINE AND STANDARD BLOOD PRESSURE TREATMENT IN PATIENTS WITH TYPE 2 DIABETES, HYPERTENSION AND NEPHROPATHY IN HUNGARY

AJ Palmer, K Borsos, S Roze, L Annemans, M Lamotte, R Rodby, WJ Valentine

Journal:

Value in Health

Year:

2003

Language:

english

File:

PDF, 84 KB

english, 2003

27

PHL12 MORE PRECISE DOSING INCREMENTS OF HUMAN GROWTH HORMONE DELIVERY SYSTEMS LEAD TO COST SAVINGS IN THE UK SETTING

M Lammert, S Roze, FM Lurati, WJ Valentine, AJ Palmer

Journal:

Value in Health

Year:

2003

Language:

english

File:

PDF, 64 KB

english, 2003

28

DB1 THE IMPACT OF USING EITHER THE FRAMINGHAM OR THE UNITED KINGDOM PROSPECTIVE DIABETES STUDY RISK FORMULAE IN DIABETES HEALTH ECONOMICS MODELING

AJ Palmer, S Roze, M Lammert, WJ Valentine, L Nicklasson

Journal:

Value in Health

Year:

2004

Language:

english

File:

PDF, 56 KB

english, 2004

29

DB6 COMPARISON OF THE COST-EFFECTIVENESS FOR BASAL-BOLUS THERAPY OF TYPE-1 DIABETES USING INSULIN DETEMIR+ INSULIN ASPART OR HUMAN INSULIN-BASED REGIMENS IN THE NETHERLANDS

Valentine Wj, K Wittrup-Jensen, AJ Palmer, S Roze

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 59 KB

english, 2005

30

PDB14 ECONOMIC EVALUATION OF DETEMIR-BASED BASAL/BOLUS THERAPY VERSUS NEUTRAL PROTAMINE HAGEDORN-BASED BASAL/BOLUS THERAPY FOR TYPE-1 DIABETES IN A DUTCH SETTING

S Roze, K Wittrup-Jensen, WJ Valentine, AJ Palmer

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 69 KB

english, 2005

31

PDB19 COLLECTION OF COST DATA FOR DIABETES COMPLICATIONS IN CANADA AND AUSTRALIA

AJ Palmer, JA Ray, S Roze, WJ Valentine, K Secnik, A Oglesby

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 85 KB

english, 2005

32

PDB13 COST OF DIABETES COMPLICATIONS IN FRANCE, GERMANY, ITALY AND SPAIN

AJ Palmer, JA Ray, S Roze, WJ Valentine, K Secnik, A Oglesby

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 86 KB

english, 2005

33

PDB37 HEALTH ECONOMIC COMPARISON OF INSULIN ASPART, A FAST-ACTING INSULIN ANALOG, VERSUS HUMAN INSULIN AS MEALTIME INSULIN IN THE TREATMENT OF TYPE-1 DIABETES IN AUSTRIAN, DANISH, DUTCH, FINNISH, FRENCH, GERMAN, NORWEGIAN, SPANISH AND SWEDISH SETTINGS

AJ Palmer, M Lammert, M Minshall, S Roze, L Nicklasson, WJ Valentine

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 66 KB

english, 2005

34

POB7 LIFETIME COSTS ASSOCIATED WITH OBESITY: A COMPUTER SIMULATION MODEL

DM Tucker, ME Minshall, AJ Palmer, WJ Valentine

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 64 KB

english, 2005

35

DB4 SELF MONITORING OF BLOOD GLUCOSE IN PATIENTS WITH TYPE 2 DIABETES: COST UTILITY ANALYSIS IN A UNITED STATES THIRD-PARTY PAYER SETTING

AJ Palmer, ME Minshall, WJ Valentine, V Foos, SL Tunis

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 71 KB

english, 2006

36

PDB12 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION VERSUS MULTIPLE DAILY INJECTION OF INSULIN IN PATIENTS WITH TYPE 1 DIABETES:A LONG-TERM HEALTH ECONOMIC ANALYSIS IN THE NORWEGIAN AND SWEDISH SETTINGS

G Goodall, L Nicklasson, K Zakrzewska, V Foos, WJ Valentine, S Roze, AJ Palmer

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 67 KB

english, 2006

37

PDB19 COMPARATIVE OUTCOMES-BASED HEALTH ECONOMIC EVALUATION OF TYPE 2 DIABETES PATIENTS ON BASAL INSULIN ANALOGS

D Cobden, WJ Valentine, C Koenen, AJ Palmer, S Roze

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 87 KB

english, 2006

38

PDB11 LONG-TERM COST-EFFECTIVENESS ANALYSIS OF REPAGLINIDE VERSUS NATEGLINIDE IN COMBINATION WITH METFORMIN IN TYPE 2 DIABETES PATIENTS FAILING MONOTHERAPY IN THE SWEDISH SETTING

J Ray, AS Brandt, V Foos, V Munro, WJ Valentine, S Roze, AJ Palmer

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 66 KB

english, 2006

39

PDB20 THERAPY CLASS CONVERSION IN PATIENTS WITH TYPE 2 DIABETES: ECONOMIC EVALUATION OF INSULIN DETEMIR AND NPH

WJ Valentine, D Cobden, AJ Palmer, S Wagner, S Roze

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 71 KB

english, 2006

40

PDB16 SELF MONITORING OF BLOOD GLUCOSE IN PATIENTS WITH TYPE 2 DIABETES: COST UTILITY ANALYSIS IN A FRENCH GOVENMENT PAYER SETTING

AJ Palmer, ME Minshall, WJ Valentine, V Foos, SL Tunis

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 88 KB

english, 2006

41

PDB17 SELF MONITORING OF BLOOD GLUCOSE IN PATIENTS WITH TYPE 2 DIABETES: COST UTILITY ANALYSIS IN A GERMAN GOVENMENT PAYER SETTING

AJ Palmer, ME Minshall, WJ Valentine, V Foos, SL Tunis

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 63 KB

english, 2006

42

PDB15 SELF MONITORING OF BLOOD GLUCOSE IN PATIENTS WITH TYPE 2 DIABETES: COST UTILITY ANALYSIS IN AN ITALIAN SETTING

AJ Palmer, ME Minshall, WJ Valentine, V Foos, SL Tunis

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 72 KB

english, 2006

43

PDB6 COST-EFFECTIVENESS OF THE ONE-TOUCH® ULTRASMART® BLOOD GLUCOSE METER COMPARED WITH A CONVENTIONAL METER FOR INSULIN-USING DIABETES PATIENTS FROM THE USA

ME Minshall, AJ Palmer, WJ Valentine

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 65 KB

english, 2006

44

PDB10 LONG-TERM CLINICAL AND ECONOMIC OUTCOMES FOR PATIENTS WITH TYPE 1 DIABETES TREATED WITH INSULIN ASPART VERSUS HUMAN SOLUBLE INSULIN IN SWEDEN

D Tucker, AS Brandt, V Foos, V Munro, G Goodall, J Ray, WJ Valentine, S Roze, AJ Palmer

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 89 KB

english, 2006

45

PDB22 EVALUATING THE LONG-TERM HEALTH OUTCOMES AND ECONOMICS OF INITIATING BIPHASIC ANALOG INSULIN COMPARED TO OPTIMIZED ORAL THERAPY ALONE

WJ Valentine, D Cobden, S Wagner, AJ Palmer, R Braceras, S Roze

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 88 KB

english, 2006

46

PDB18 COST-EFFECTIVENESS OF ACARBOSE IN PATIENTS WITH TYPE-2 DIABETES IN THREE COUNTRIES

T Evers, S Roze, AJ Palmer, WJ Valentine, D Tucker, M Hanefeld

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 63 KB

english, 2006

47

PDB21 ECONOMIC EVALUATION OF INITIATING INSULIN DETEMIR AMONG TYPE 2 DIABETES PATIENTS RECEIVING ORAL MEDICATION

AJ Palmer, D Cobden, WJ Valentine, S Wagner, S Roze

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 71 KB

english, 2006

48

PCV35 ESTIMATING LIFETIME COSTS AND LIFE EXPECTANCY ASSOCIATED WITH CARDIOVASCULAR DISEASE IN A SWISS POPULATION WITH AND WITHOUT METABOLIC SYNDROME

J Ray, R Darioli, S Roze, M Azoulay, M Bernhardt, WJ Valentine

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 87 KB

english, 2006

49

PCV17 PROJECTED IMPACT ON CORONARY HEART DISEASE OF ADDING PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) TO STATIN TREATMENT IN EUROPEAN PATIENTS WITH TYPE 2 DIABETES

D Liens, AJ Palmer, WJ Valentine, C Renaudin, S Roze

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 71 KB

english, 2006

50

PCV31 HEALTH ECONOMIC ASSESSMENT OF RAISING HDL-C WITH PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) WHEN ADDED TO STATIN THERAPY IN PATIENTS WITH DYSLIPIDEMIA AND TYPE 2 DIABETES:AN ANALYSIS FOR SWEDEN

C Renaudin, D Liens, AJ Palmer, WJ Valentine, W Berger, S Roze

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 71 KB

english, 2006

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски